2456. Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4–6 Years After Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy US Adolescents and Adults

BACKGROUND: Neisseria meningitidis serogroups A, B, C, W, and Y are a leading cause of bacterial meningitis and sepsis worldwide. Infants <1 year, adolescents and young adults are at the highest risk. The US Advisory Committee on Immunization Practices (ACIP) recommends routine MenACWY conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tipton, Mary, Daly, Wendy, Senders, Shelly, Block, Stanley L, Keshavan, Pavitra, Mzolo, Thembile, Pellegrini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254311/
http://dx.doi.org/10.1093/ofid/ofy210.2109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254311/
http://dx.doi.org/10.1093/ofid/ofy210.2109

Ejemplares similares